The PE firm invested ₹70 crore each in ophthalmology hospital chain Sharp Sight and Pune-based Murli Krishna Pharma Pvt. Ltd, a formulations maker that focuses on developing novel drug delivery system (NDDS) products.
Loading - Please wait
Date posted: Friday 3 July 2020
The PE firm invested ₹70 crore each in ophthalmology hospital chain Sharp Sight and Pune-based Murli Krishna Pharma Pvt. Ltd, a formulations maker that focuses on developing novel drug delivery system (NDDS) products.